This ‘‘CD19/CD22 loop’’ could be directly related to an autoimmune phenotype in mice, so that it could be an attractive therapeutic target for regulating B cell signaling in autoimmune diseases (7). This evidence concerns the gene CD19 and autoimmune disease.